Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%) Glenmark Life Sciences informs about media release
Date: 19-01-2024Glenmark Life Sciences has informed that it enclosed a media release titled ‘Glenmark Life Sciences Signs Master Supply Agreement with a leading Japanese innovator pharmaceutical company’.
The above information is a part of company’s filings submitted to BSE.